Study of n-Acetyltransferase-1 en -2 (NAT-1, NAT-2) and other polymorphisms in persons with contactallergy for p-Phenylenediamine (PPD)

Recruiting

• Conditions: contact allergy; 10014982

• Registration Number: NL-OMON30831
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 400

Inclusion Criteria

positive patch-test on p-phenylenediamine or p-toluenediamine

Exclusion Criteria

legally incompetent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The odds-ratios of the proportional frequencies of NAT-1 and NAT-2 variants in<br /><br>patients with a contactallergy to PPD.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.a.</p><br>